2.10 (-%)
As of Nov 12, 2024
Source:
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel small molecule product candidates to address a range of inflammatory diseases with significant unmet need. We leverage the substantial experience of our team in immunology to identify important new targets and to develop differentiated therapeutics against these targets.
Country | United States |
Headquarters | san diego, california |
Phone Number | ( 760 ) 593-4832 |
Industry | manufacturing |
CEO | Raju Mohan |
Website | ventyxbio.com |